SCHEMBL19731897

SCHEMBL19731897

CC(=O)N(CC(C)C)c1cccc(O)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
CYP3A4 P08684 2/20 0.46
TSHR P16473 1/20 0.46
ITGB1 P05556 1/20 0.43
ITGA4 P13612 1/20 0.43
OPRM1 P35372 5/20 0.41
OPRK1 P41145 5/20 0.41
OPRD1 P41143 4/20 0.41
BCL2L1 Q07817 3/20 0.39
MCL1 Q07820 3/20 0.39
CYP1A2 P05177 1/20 0.38
HSD17B1 P14061 1/20 0.37
HSD17B2 P37059 1/20 0.37
SLC22A1 O15245 1/20 0.37
ADRA1D P25100 2/20 0.36
ADRA1A P35348 2/20 0.36
ADRA1B P35368 2/20 0.36
LMNA P02545 1/20 0.36
HTR1A P08908 1/20 0.36
ADRA2A P08913 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8121494 0.81 ALDH1A1 (0.50) ALDH1A1CYP3A4TSHRITGB1ITGA4
SCHEMBL5648495 0.80 ITGB1 (0.48) ALDH1A1CYP3A4TSHRITGB1ITGA4
SCHEMBL6340899 0.79 MCL1 (0.43) ALDH1A1CYP3A4ITGB1ITGA4OPRK1
SCHEMBL6907862 0.79 ALDH1A1 (0.47) ALDH1A1CYP3A4TSHRHSD17B1HSD17B2
SCHEMBL6908896 0.78 ALDH1A1 (0.63) ALDH1A1CYP3A4TSHROPRM1OPRK1
SCHEMBL6903155 0.75 LMNA (0.45) ALDH1A1CYP3A4TSHRCYP1A2HSD17B1
SCHEMBL19731898 0.75 MCL1 (0.56) ALDH1A1CYP3A4TSHRBCL2L1MCL1
SCHEMBL9618596 0.75 ALDH1A1 (0.50) ALDH1A1CYP3A4TSHROPRM1OPRK1
SCHEMBL9310893 0.74 ALDH1A1 (0.44) ALDH1A1CYP3A4TSHRBCL2L1MCL1
SCHEMBL9304794 0.73 ALDH1A1 (0.73) ALDH1A1CYP3A4TSHROPRM1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170360667-A1 NEW COMPOUNDS IN THE FAMILY OF N-ACYLAMINO-AMIDES, COMPOSITIONS COMPRISING THEM, AND USES L'OREAL (FR) 2017-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170360667-A1 NEW COMPOUNDS IN THE FAMILY OF N-ACYLAMINO-AMIDES, COMPOSITIONS COMPRISING THEM, AND USES H1-0, CRY1, CCNA1 ALDH1A1 736/4885CYP3A4 3459/4885TSHR 1299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.